TENDENCY OF INCIDENCE WITH NONSPECIFIC ULCERATIVE COLITIS IN KAZAKHSTAN
DOI:
https://doi.org/10.31082/1728-452X-2020-221-222-11-12-8-12Keywords:
nonspecific ulcerative colitis, morbidity, trends, Kazakhstan.Abstract
Nonspecific ulcerative colitis is a chronic inflammatory bowel disease of an immune nature with frequent localization in the large intestine. A pattern is noted that in the northern and western continents they suffer more often than in Asia. To identify risk factors in a population, epidemiological studies must firstly assess the incidence of disease.
Aim. To study the trends of nonspecific ulcerative colitis (NUC) incidence in Kazakhstan.
Material and methods. The research material was compiled summary reporting form number 12 of the Ministries and the Health of the Republic of Kazakhstan on new cases of nonspecific ulcerative colitis (ICD-10 – K51), established for the first time. A retrospective study was used as the main method for studying the incidence of NUC. According to generally accepted methods of biomedical statistics, extensive, intensive and equalized indicators of the incidence of NUC were calculated.
Results and discussion. For 2013-2018 14,079 new cases of NUC were registered in the republic, of which 15 were in children – 15.3%, teenagers – 4.8% and adults – 79.8%. The average annual incidence rate of NUC in the entire population of Kazakhstan was 13.5±2.10/0000 (95% CI=9.4-17.50/0000), and for population groups having been studied was: in children – 7.2±2.10/0000 (95%CI=3.8-12.00/0000), among teenagers – 18.7±5.00/0000 (95% CI=9.0-28.50/0000) and the adult population 15.4±1.90/0000 (95% CI=11.8-19.10/0000). The difference in morbidity between groups was statistically significant. Disease tended to decrease in all age groups: in the adult population (Т=−12.3%), children (Т=−43.7%) and in adolescents (T=-50.1%).
Conclusion. According to the dynamics, NUC incidence in Kazakhstan has a decreased tendency due to the child and adolescent population. The results obtained are recommended to be taken into account by health authorities when making managerial decisions.
References
Khalif IL, Loranskaya ID, Miklosh M. Nespetsificheskii iazvennyi kolit i bolezn Krona: klinika, diagnostika i lechenie − Vospalitelnye zabolevaniia kishechnika [Nonspecific ulcerative colitis and Crohn's disease: clinical picture, diagnosis and treatment. Inflammatory bowel disease]. Russia: Miklosh;2004:88
Kappelman MD, Moore KR, Allen JK, Cook SF. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2013;58(2):519-525. doi: 10.1007/s10620-012-2371-5
Dolgushina AI, Khusainova GM, Vasilenko AG, Kononets VA. Prevalence of inflammatory bowel disease in the Chelyabinsk Region. Almanakh klinicheskoi meditsiny = Almanakh clinical medicine. 2019.47(6):511-517 (in Russ). doi: 10.18786/2072-0505-2019-47-066
Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017; Vol 44(4):673-692. DOI: 10.1016/j. pop.2017.07.010
Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. Hindawi. Journal of Immunology Research. 2019. A r ticle ID 7247238; 16 р. doi: 10.1155/2019/7247238
Conrad MA, Rosh JR. Pediatric Inflammatory Bowel Disease. Pediatr Clin North Am. 2017; Vol 64(3):577-591. doi: 10.1016/j.pcl.2017. 01.005
Yesmagambetova E, Turebayev D, Kozhakhmetov S, Igissinov N. Incidence of nonspecific ulcerative colitis in Kazakhstan. Meditsina (Kaunas) = Medicine (Kaunas). 2020;56(1):154. (In Russ.)
Teleuolova AS, Beysenbekova ZhA, Tayzhanova DZh, Teuesheva ZB, Guseinova ZK. Nonspecific ulcerative colitis in combination with rheumatoid arthritis (case report). Meditsinskie novosti Gruzii = Georgian Med News. 2015;(238):70-2 (In Russ.). PMID: 25693218
Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91-9. doi: 10.3748/wjg.v20.i1.91
Malik TA. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015;95(6):1105-22. doi: 10.1016/j.suc.2015.07.006
Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133(5):1670-1689. doi: 10.1053/j. gastro.2007.09.001. PMID: 17983810
Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015;169(11):1053- 60. doi: 10.1001/jamapediatrics
Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14(2):145-53. doi: 10.1046/ j.1365-2036.2000.00698.x
Mak WY, Zhao M, Ng SC, Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020; Vol 35(3):380-389. DOI: 10.1111/jgh.14872
Berg DR, Colombel JF, Ungaro R. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25(12):1896-1905. doi: 10.1093/ibd/izz059